For HTLV-1-associated T cell lymphomas and KSHV-associated primary effusion lymphoma, CADM1 has been described to support viral oncogene-driven NF-κB activation, and thereby to directly drive transformed lymphocyte proliferation [30, 31]. This evidence concerns the gene CADM1 and T-cell non-Hodgkin lymphoma.